The impaired capacity of htgUGT1A-SNP mice to eliminate potential FXR or PPARα ligands may improve the PPARα-mediated mitochondrial fatty acid oxidation, hepatic fatty acid uptake, peroxisomal beta-oxidation or other crucial processes of lipid metabolism and leads to the lower degree of hepatic steatosis. Here, NR1H4 is linked to fatty liver disease.